CI
52
-7
VLO
42
2
T
48
3
TXN
49
-6
DOW
30
2
GILD
56
-4
LOW
58
2
AAPL
45
3
VZ
42
3
DFS
67
-3
KLAC
45
-4
QRVO
4
-2
LRCX
46
-2
NOV
58
-2
TAP
64
4
PFG
50
-2
ABT
57
-5
CTSH
65
-3
SJM
16
-3
FRT
48
2
CI
52
-7
VLO
42
2
T
48
3
TXN
49
-6
DOW
30
2
GILD
56
-4
LOW
58
2
AAPL
45
3
VZ
42
3
DFS
67
-3
KLAC
45
-4
QRVO
4
-2
LRCX
46
-2
NOV
58
-2
TAP
64
4
PFG
50
-2
ABT
57
-5
CTSH
65
-3
SJM
16
-3
FRT
48
2
Financhill
Back

Range Cancer Therapeutics ETF Vs. ePlus Industry Stock Comparison

Sell
44

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.50
Seasonality Move:
1.85%
Sell
27

PLUS
ePlus

Last Price:
80.84
Seasonality Move:
20.86%
Sell
44
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $14.80. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $14.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 45.09 Sell
Chaikin Money Flow: -2025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.73 - 15.45) Sell
Bollinger Bands (100): (14.08 - 15.46) Buy

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: -371573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.15 - 100.85) Sell
Bollinger Bands (100): (81.19 - 98.29) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.36 Sell
20-day SMA: 15.14 Sell
50-day SMA: 15.08 Sell
200-day SMA: 15.09 Sell
8-day EMA: 15.24 Sell
20-day EMA: 15.16 Sell
50-day EMA: 15.03 Sell
200-day EMA: 14.63 Buy

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.25 Sell
20-day SMA: 94.97 Sell
50-day SMA: 95.27 Sell
200-day SMA: 83.59 Sell
8-day EMA: 92.26 Sell
20-day EMA: 94.28 Sell
50-day EMA: 94.05 Sell
200-day EMA: 84.44 Sell

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):